aid: d2g-oncology
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/d2g-oncology.png
name: D2G Oncology
description: >-
  D2G Oncology is a precision-oncology company based in Mountain View, California, reported to have
  been founded in 2018 by Ian Winters. Public company descriptions characterize its work as applying
  quantitative and multiplexed functional cancer genomics to relate drugs to genotypes in order to
  advance precision cancer therapeutics. The company operates INSITE, a login-gated internal research
  portal at www.d2g-insite.com supporting preclinical study management and result exploration. D2G
  Oncology publishes no public developer API program, no developer portal, no API documentation, and
  no client SDKs, and third-party company trackers list the company as inactive as of 2026. It was
  surfaced through the Lightspeed Venture Partners portfolio and is retained here as an identity-only
  profile.
url: https://raw.githubusercontent.com/api-evangelist/d2g-oncology/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- lightspeed-venture-partners
x-tier: stub
x-tier-reason: no-public-api-program
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Oncology
- Healthcare
- Biotechnology
- Therapeutics
- Life Sciences
- Precision Medicine
- Functional Genomics
apis: []
common:
- type: DomainSecurity
  url: security/d2g-oncology-domain-security.yml
- type: Website
  url: https://www.d2g-insite.com/
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-20'
  status: minimal
  artifacts_added: 1
  pass: local-v1
x-notes:
  no-api-program: >-
    Enrichment pass 2026-07-20 found no public developer API surface: no developer portal, no
    documentation site, no consumer-facing OpenAPI/AsyncAPI/GraphQL, no first-party SDKs in npm,
    PyPI, Maven Central, NuGet, RubyGems, Packagist or crates.io, and no usable /.well-known
    artifacts. Every path probed on www.d2g-insite.com returns the single-page-app shell with HTTP
    200 (soft 404), so security.txt, llms.txt, openid-configuration and api-catalog are all absent
    despite returning 200 status codes.
  domain-warning: >-
    d2goncology.com is NO LONGER controlled by D2G Oncology. As of 2026-07-20 that domain serves an
    unrelated Dubai travel business (Andaleeb Travel Agency) and presents a TLS certificate valid
    only for *.web-hosting.com. Do not add it as a company property in future enrichment rounds. The
    only live company-controlled property found is www.d2g-insite.com.